blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP4110467

EP4110467 - BROAD-SPECTRUM ANTIVIRAL PEPTIDES [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  02.12.2022
Database last updated on 02.09.2024
FormerThe international publication has been made
Status updated on  08.06.2022
Most recent event   Tooltip28.03.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
The Administrators of the Tulane Educational Fund
1430 Tulane Avenue
New Orleans, LA 70112 / US
[2023/01]
Inventor(s)01 / WIMLEY, William, Charles
1430 Tulane Avenue
New Orleans, LA 70112 / US
02 / HOFFMANN, Andrew Robert
1430 Tulane Avenue
New Orleans, LA 70112 / US
03 / GARRY, Robert F.
1430 Tulane Avenue
New Orleans, LA 70112 / US
 [2023/01]
Representative(s)Dehns
St. Bride's House
10 Salisbury Square
London EC4Y 8JD / GB
[2023/01]
Application number, filing date21780752.831.03.2021
[2023/01]
WO2021US25280
Priority number, dateUS202063002522P31.03.2020         Original published format: US 202063002522 P
[2023/01]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2021202816
Date:07.10.2021
Language:EN
[2021/40]
Type: A1 Application with search report 
No.:EP4110467
Date:04.01.2023
Language:EN
The application published by WIPO in one of the EPO official languages on 07.10.2021 takes the place of the publication of the European patent application.
[2023/01]
Search report(s)International search report - published on:US07.10.2021
(Supplementary) European search report - dispatched on:EP23.02.2024
ClassificationIPC:A61P31/12, C07K7/00, C07K14/00
[2023/01]
CPC:
C07K7/06 (EP,US); C07K14/001 (EP,US); A61K39/215 (US);
A61K39/39 (US); A61P31/12 (EP); A61P31/14 (US);
A61P31/16 (US); A61P31/22 (US); C07K7/08 (EP,US);
A61K2039/53 (US); A61K2039/545 (US); A61K2039/55516 (US);
A61K38/00 (EP); C12N2770/20034 (US); C12N2770/20071 (US);
Y02A50/30 (EP) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2023/01]
TitleGerman:ANTIVIRALE PEPTIDE MIT BREITEM SPEKTRUM[2023/01]
English:BROAD-SPECTRUM ANTIVIRAL PEPTIDES[2023/01]
French:PEPTIDES ANTIVIRAUX À LARGE SPECTRE[2023/01]
Entry into regional phase28.09.2022National basic fee paid 
28.09.2022Search fee paid 
28.09.2022Designation fee(s) paid 
28.09.2022Examination fee paid 
Examination procedure28.09.2022Examination requested  [2023/01]
18.04.2023Amendment by applicant (claims and/or description)
Fees paidRenewal fee
31.03.2023Renewal fee patent year 03
27.03.2024Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]US2004123343  (LA ROSA THOMAS J [US], et al) [X] 1-7,10-12 * Title; Abstract; SEQ 122913 *;
 [X]WO2011056212  (PROTEREC LTD [IL], et al) [X] 1-7,10-12 * Title; Abstract; SEQ. ID. No.: 7 *;
 [X]  - Anonymous, "UPI0007A1D356", UNIPARC, (20160406), Database accession no. UPI0007A1D356, URL: https://www.uniprot.org/uniparc/UPI0007A1D356/entry, XP093130097 [X] 1,2,6,12 * abstract *
 [Y]  - RATHINAKUMAR RAMESH ET AL, "Biomolecular Engineering by Combinatorial Design and High-Throughput Screening: Small, Soluble Peptides That Permeabilize Membranes", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, (20080701), vol. 130, no. 30, doi:10.1021/ja8017863, ISSN 0002-7863, pages 9849 - 9858, XP093129416 [Y] 1-15 * Title; Abstract; Figures 1, 2 *

DOI:   http://dx.doi.org/10.1021/ja8017863
 [Y]  - RAMESH RATHINAKUMAR ET AL, "Broad-Spectrum Antimicrobial Peptides by Rational Combinatorial Design and High-Throughput Screening: The Importance of Interfacial Activity", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, (20090610), vol. 131, no. 22, doi:10.1021/ja8093247, ISSN 0002-7863, pages 7609 - 7617, XP055012553 [Y] 1-15 * Title; Abstract; Fig. 1 *

DOI:   http://dx.doi.org/10.1021/ja8093247
 [Y]  - RATHINAKUMAR RAMESH ET AL, "High-throughput discovery of broad-spectrum peptide antibiotics", THE FASEB JOURNAL, US, vol. 24, no. 9, doi:10.1096/fj.10-157040, ISSN 0892-6638, (20100911), pages 3232 - 3238, URL: https://onlinelibrary.wiley.com/doi/full-xml/10.1096/fj.10-157040, XP093129400 [Y] 1-15 * Title; Abstract; Fig. 3 *

DOI:   http://dx.doi.org/10.1096/fj.10-157040
 [Y]  - JING HE ET AL, "Toward the de novo design of antimicrobial peptides: Lack of correlation between peptide permeabilization of lipid vesicles and antimicrobial, cytolytic, or cytotoxic activity in living cells", BIOPOLYMERS, JOHN WILEY, HOBOKEN, USA, (20140117), vol. 102, no. 1, doi:10.1002/BIP.22281, ISSN 0006-3525, pages 1 - 6, XP071048053 [Y] 1-15 * Title; Abstract; Fig. 1 *

DOI:   http://dx.doi.org/10.1002/bip.22281
 [Y]  - HE JING ET AL, "Novel Antiviral Agents: Design, Identification and Characterization of Interfacially Active Peptide Entry inhibitors", THE FASEB JOURNAL, US, vol. 29, no. S1, doi:10.1096/fasebj.29.1_supplement.886.20, ISSN 0892-6638, (20150401), URL: https://dx.doi.org/10.1096/fasebj.29.1_supplement.886.20, XP093129738 [Y] 1-15 * the whole document *

DOI:   http://dx.doi.org/10.1096/fasebj.29.1_supplement.886.20
 [Y]  - HOFFMANN ANDREW, "Randomly Selected Hydrophobic Peptides Inhibit Lassa Pseudovirus", BIOPHYSICAL JOURNAL, (20150127), vol. 108, no. 2, doi:10.1016/J.BPJ.2014.11.487, ISSN 0006-3495, XP029191925 [Y] 1-15 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.bpj.2014.11.487
 [Y]  - BADANI HUSSAIN ET AL, "Peptide entry inhibitors of enveloped viruses: The importance of interfacial hydrophobicity", BIOCHIMICA ET BIOPHYSICA ACTA, AMSTERDAM, NL, (20140901), vol. 1838, no. 9, doi:10.1016/j.bbamem.2014.04.015, ISSN 0005-2736, pages 2180 - 2197, XP093129410 [Y] 1-15 * Title; Abstract; last two sentences of the introduction; table 1; Figures 3-11; p. 2194 "4.4 Entry inhibition by membrane-permeabilizing, cationic antimicrobial peptides" *

DOI:   http://dx.doi.org/10.1016/j.bbamem.2014.04.015
 [XP]  - Hoffmann Andrew Robert, "Discovery and design of broad-spectrum antiviral peptides", Discovery and design of broad-spectrum antiviral peptides, Dissertation, Tulane University, (20200331), pages 1 - 194, XP093129943 [XP] 1-15 * the whole document *
 [XPI]  - HOFFMANN ANDREW R. ET AL, "Broad-Spectrum Antiviral Entry Inhibition by Interfacially Active Peptides", JOURNAL OF VIROLOGY, US, vol. 94, no. 23, doi:10.1128/JVI.01682-20, ISSN 0022-538X, (20200909), URL: https://journals.asm.org/doi/pdf/10.1128/JVI.01682-20, XP093129396 [XP] 8,14 * the whole document * [I] 1-15

DOI:   http://dx.doi.org/10.1128/JVI.01682-20
International search[A]US6620923  (SPECHT THOMAS [DE], et al) [A] 1-4, 27, 71-136* entire document *;
 [Y]US2009099533  (MONTELARO RONALD C [US], et al) [Y] 109 * entire document *;
 [A]US7745391  (MINTZ LIAT [US], et al) [A] 1-4, 27, 71-136 * entire document *;
 [Y]US2011150917  (HANCOCK ROBERT E [CA], et al) [Y] 79 * entire document *;
 [A]US2012017292  (KOVALIC DAVID K [US], et al) [A] 1-4, 27, 71-136 * entire document *;
 [Y]US2012178649  (WATT PAUL M [AU], et al) [Y] 78 * entire document *;
 [Y]WO2019084343  (THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND [US]) [Y] 74, 111-114, 116-118 * entire document *;
 [XY]US2019192691  (BARRETT PETER [US], et al) [X] 1, 2, 4, 27, 71-73, 75-77, 80-107, 110, 119-136 * entire document * [Y] 74, 78, 79, 108, 109, 111-114, 116-118;
 [Y]  - Lifetein Peptide, "The Cationic Host Defense Peptides Could Be Used To Kill Enveloped Novel Coronavirus SARS-CoV-2", LifeTein Blog, (20200228), LifeTein Blog, URL: https://www.lifetein.com/blog/the-cationic-host-defense-peptides-could-be-used-to-kill-enveloped-novel-coronavirus-sars-cov-2/, (20220523), XP055924124 [Y] 108
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.